STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Companies Large-Cap
code-4

Synopsys Beats Expectations in Q1 Financial Report

byLiliana Vida
February 22, 2024
in Large-Cap, Software
Reading Time: 1 min read
Share on TwitterShare on LinkedIn

Synopsys, Inc. unveiled its first-quarter financial results after Wednesday’s market closure, showcasing impressive performance across key metrics.

The company reported quarterly earnings of $3.56 per share, surpassing the analyst consensus estimate of $3.43 by 3.79%. Quarterly sales amounted to $1.65 billion, aligning with analyst expectations and reflecting a notable 21.16% increase compared to the same period last year.

Sassine Ghazi, CEO of Synopsys, expressed satisfaction with the strong start to the year, emphasizing the company’s robust execution and the pivotal role of AI in driving customer investments.

Ghazi highlighted the significance of Synopsys’ technology and strategic approach, particularly in navigating the complexities of modern design processes. With mounting design challenges, technology R&D teams rely on Synopsys’ comprehensive portfolio of semiconductor IP and cutting-edge design solutions.

Looking ahead, Synopsys anticipates second-quarter adjusted earnings between $3.09 and $3.14 per share, surpassing the $3.01 estimate. Revenue for the second quarter is projected to range between $1.56 billion and $1.59 billion, exceeding the $1.55 billion estimate.

For the full year 2024, Synopsys forecasts adjusted earnings per share in the range of $13.47 to $13.55, surpassing the $13.42 estimate. Revenue for the fiscal year is expected to be between $6.57 billion and $6.63 billion, slightly below the $6.62 billion estimate.

Previous Post

Dutch Bros Exceeds Expectations in Q4 Financial Report

Next Post

AbbVie Plans $13 Billion Bond Sale for Acquisitions

Related Posts

chemistry

Viking Therapeutics: A High-Stakes Year in the Obesity Drug Race

byLuca Blaumann
April 8, 2026
0

Late-stage pipeline progress and market momentum position the biotech as a key emerging player Viking Therapeutics (VKTX) is entering a...

Delta Airlines Beats Expectations as Premium Demand Fuels Growth

byLuca Blaumann
April 8, 2026
0

Airline navigates rising fuel costs with strong margins, loyalty revenue, and strategic advantages Delta Airlines (DAL) delivered stronger-than-expected first quarter...

Global Markets Surge in Relief Rally as Geopolitical Tensions Ease

byLuca Blaumann
April 8, 2026
0

Stocks climb sharply while oil prices plunge, fueling renewed investor optimism Global markets rallied strongly today as investors reacted to...

Next Post
drugs-4

AbbVie Plans $13 Billion Bond Sale for Acquisitions

Latest News

Viking Therapeutics: A High-Stakes Year in the Obesity Drug Race

Delta Airlines Beats Expectations as Premium Demand Fuels Growth

Global Markets Surge in Relief Rally as Geopolitical Tensions Ease

Health Insurers Rally as Medicare Advantage Payments Get Major Boost

Ulta Beauty’s Next Chapter: Expansion, Innovation, and AI-Driven Growth

Based on Your Interest

Bitcoin

Bitcoin Reclaims $70K Amid Geopolitical Tensions and Market Short Squeeze

April 6, 2026
bitcoin-3
Asset Management

Coinbase Moves Closer to Banking Status with Federal Approval

April 2, 2026
tesla
Artificial Intelligence

Tesla Deliveries Miss Expectations Amid Rising Global Competition

April 2, 2026

Recommended

Energy

Sky Quarry Gains Momentum on Nevada Production Talks

April 2, 2026
Ecommerece

Globalstar Rallies on Amazon Acquisition Speculation

April 2, 2026
Artificial Intelligence

Biotech and Tech Stocks Surge on Strategic Deals and Revenue Momentum

April 1, 2026
Artificial Intelligence

Intel Reclaims Strategic Control in Ireland Amid AI-Driven Comeback

April 1, 2026
Large-Cap

Nike Navigates Mixed Quarter as Strategic Reset Takes Hold

March 31, 2026
Stoxpo

Follow us on social media:

Highlights

  • Viking Therapeutics: A High-Stakes Year in the Obesity Drug Race
  • Delta Airlines Beats Expectations as Premium Demand Fuels Growth
  • Global Markets Surge in Relief Rally as Geopolitical Tensions Ease
  • Health Insurers Rally as Medicare Advantage Payments Get Major Boost
  • Ulta Beauty’s Next Chapter: Expansion, Innovation, and AI-Driven Growth

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

chemistry

Viking Therapeutics: A High-Stakes Year in the Obesity Drug Race

April 8, 2026

Delta Airlines Beats Expectations as Premium Demand Fuels Growth

April 8, 2026

Global Markets Surge in Relief Rally as Geopolitical Tensions Ease

April 8, 2026
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.